ASTRID POZET

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
The combination of cisplatin or carboplatin and etoposide is the standard treatment for certain poorly differentiated neuroendocrine cancers, such as small-cell lung cancer. The aim of this study was to assess the efficacy and tolerability of the carboplatin-etoposide regimen in metastatic castra-tion-resistant prostate cancer (mCRPC). A total of 27(More)
  • 1